• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

Balanced Crystalloids or Saline IV for Patients admitted to the ICU?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Historically, 0.9% sodium chloride (saline) has been the most widely used IV solution
    • Some data to suggest association with hyperchloremic metabolic acidosis, acute kidney injury and death
  • Alternative is a balanced crystalloid solution, such as lactated Ringer’s solution
    • Closer electrolyte composition to plasma
    • Data suggests less acute kidney impairment and death but literature is inconsistent
  • Semler et al. (N Eng J Med 2018) sought to determine which intravenous fluid administration, balanced crystalloids or saline, results in better clinical outcomes in the ICU setting

METHODS:

  • Pragmatic, cluster-randomized, multiple-crossover trial of patients in the ICU
    • Adverse Renal Events Trial (SMART), which compared the use of balanced crystalloids with the use of saline in patients in medical (SMART-MED) and nonmedical (SMART-SURG) intensive care units (ICUs)
  • Participants: ≥18 years of age, admitted to participating ICU
  • Patients received either:
    • Balanced crystalloids (lactated Ringer’s solution or Plasma-Lyte A)
    • Saline
  • The primary outcome
    • Proportion of patients who met one or more criteria for a major adverse kidney event within 30 days
      • Composite of all-cause mortality, new renal-replacement therapy, or persistent renal dysfunction
    • Secondary outcomes
      • Death before ICU discharge or at 30 days or 60 days | ICU-free days | ventilator-free days | vasopressor-free days | days alive and free of renal-replacement therapy during the 28 days after enrollment
      • Renal specific: New receipt of renal-replacement therapy | persistent renal dysfunction | acute kidney injury of stage 2 or higher | highest creatinine level during the hospital stay | change from baseline to the highest creatinine level | final creatinine level before hospital discharge

RESULTS:

  • 15,802 ICU patients were enrolled
    • 7,924 patients were in balanced crystalloids group and 7860 patients were in the saline group
    • Median age 58 years
    • 42.4% were women
    • Median volume of balanced crystalloids was 1000 ml and 1020 in the saline group
  • Primary outcome for adverse kidney events was higher in saline group (P=0.04)
    • balanced crystalloids (14.3%) compared to saline (15.4%)
    • Secondary outcomes
      • In-hospital mortality, incidence of new renal-replacement therapy and persistent renal function did not differ significantly between groups, nor did other secondary outcomes

CONCLUSION:

  • Among critically ill adults, balanced crystalloids for intravenous fluid administration reduced the rate of composite adverse outcome that included all-cause mortality, new renal-replacement therapy, or persistent renal dysfunction
  • Saline has higher chloride content that may be responsible for kidney injury
  • While the primary care difference was only a 1.1% difference, over treatment of millions admitted to ICUs, the difference becomes substantial
  • Clinical context is important and therefore clinicians had the option of using only saline when treating brain injury as balanced crystalloids may be too hypotonic
  • The authors acknowledge that the use of composite outcomes introduces confounding variables and additional studies are needed

Learn More – Primary Sources:

Balanced Crystalloids versus Saline in Critically Ill Adults

image_pdfFavoriteLoadingFavorite

< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

Can Maternal Pulse Pressure be Used to Determine the Need for Fluid Bolus Prior to Epidural?
Fatty Liver of Pregnancy: A True Obstetric Emergency

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site